Desq Long
Sign in

Cluster

QNRX-2026-08-31-734950de1d71

SEC FORM 4CLUSTER · 4 INSIDERS
$279,965.60

Quoin Pharmaceuticals, Ltd. (QNRX)

Purchase of 57,370 shares across 4 reporting persons.

Transaction Code P · Reporting Persons 4

  • Carter Denise P., Chief Operating OfficerPurchase of 20,490 shares at $4.88 per share.$99,991.20
  • Culverwell Anthony JamesPurchase of 6,146 shares at $4.88 per share.$29,992.48
  • Lawlor Sally Bridget, Chief Financial OfficerPurchase of 10,244 shares at $4.88 per share.$49,990.72
  • Myers Michael, Chief Executive OfficerPurchase of 20,490 shares at $4.88 per share.$99,991.20

Surfaced by rule: 4 distinct insiders, open-market purchases, 7-day window — a deterministic filter, not a recommendation.

Traded Aug 31, 2026 · Disclosed Sep 1, 2026

Source: SEC Form 4 · 0001104659-26-104405 · filed 2026-09-01 · View filing →

Source: SEC Form 4 · 0001104659-26-104402 · filed 2026-09-01 · View filing →

Source: SEC Form 4 · 0001104659-26-104403 · filed 2026-09-01 · View filing →

Source: SEC Form 4 · 0001104659-26-104404 · filed 2026-09-01 · View filing →

Permalink →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Quoin Pharmaceuticals, Ltd. (QNRX)." Disclosed 2026-09-01. https://desqlong.com/cards/cluster-QNRX-2026-08-31-734950de1d71 (retrieved 2026-09-26).